指南与共识复苏、休克与脓毒症重症综合管理与镇静镇痛

儿童重症非出血性休克红细胞输注推荐:儿科重症输血与贫血专家倡议

Recommendations on RBC Transfusions for Critically Ill Children With Nonhemorrhagic Shock From the Pediatric Critical Care Transfusion and Anemia Expertise Initiative.
指南 / 共识 · Pediatr Crit Care Med · 2018-01-01
一句话结论儿科重症输血与贫血专家倡议推荐:血流动力学稳定的严重脓毒症或脓毒性休克患儿,血红蛋白≥7 g/dL时不予红细胞输注。

儿科重症输血与贫血专家倡议通过共识会议制定儿童重症非出血性休克的红细胞输注推荐。38名国际多学科专家参与,非出血性休克亚组5人,检索1980年至2017年5月PubMed、EMBASE和Cochrane Library,采用RAND/UCLA适宜性方法和GRADE分级。共形成4条临床推荐和4条研究推荐,全部达成>80%的共识;4条临床推荐中3条基于共识专家组意见,1条基于弱的儿科证据。推荐对血流动力学稳定、诊断为严重脓毒症或脓毒性休克的危重患儿,血红蛋白≥7 g/dL时不予红细胞输注;未来需研究确定非出血性休克患儿急性复苏期间的最佳输血阈值。

要点

  • 血流动力学稳定的严重脓毒症或脓毒性休克患儿,血红蛋白≥7 g/dL时推荐不予红细胞输注(基于弱的儿科证据)。
  • 该推荐来自儿科重症输血与贫血专家倡议共识会议,38名专家参与,非出血性休克亚组5人,全部推荐共识度>80%。
  • 4条临床推荐中3条基于共识专家组意见,仅1条基于弱的儿科证据,儿童证据稀少。
  • 未来需研究确定非出血性休克患儿急性复苏期间的最佳输血阈值。

适用人群与场景

  • 危重儿童中诊断为非出血性休克者,包括血流动力学稳定的严重脓毒症或脓毒性休克患儿。

诊断标准与关键阈值

  • 血流动力学稳定的严重脓毒症或脓毒性休克患儿,血红蛋白浓度≥7 g/dL为不予红细胞输注的阈值。

处置流程与药物剂量

  • 对血流动力学稳定、诊断为严重脓毒症或脓毒性休克的危重患儿,血红蛋白≥7 g/dL时推荐不予红细胞输注(基于弱的儿科证据)。

研究设计与关键结果

  • 共识会议系列由38名国际多学科专家参与,非出血性休克亚组5名专家;检索PubMed、EMBASE和Cochrane Library 1980年至2017年5月文献;采用RAND/UCLA适宜性方法达成共识,GRADE方法总结结果。
  • 共制定4条临床推荐和4条研究推荐,全部推荐达成>80%共识;4条临床推荐中3条基于共识专家组意见,1条基于弱的儿科证据。
  • 推荐对血流动力学稳定的严重脓毒症或脓毒性休克患儿,血红蛋白≥7 g/dL时不予红细胞输注。

证据类型、等级与局限

  • 证据类型:国际多学科专家共识会议(指南/共识),采用GRADE方法分级。
  • 4条临床推荐中3条基于共识专家组意见,1条基于弱的儿科证据;全部推荐共识度>80%。
  • 局限:现有儿科证据稀少,揭示文献存在显著空白;未来需研究确定非出血性休克患儿急性复苏期间的最佳输血阈值。

对床旁实践的改变

  • 对血流动力学稳定的严重脓毒症或脓毒性休克患儿,当血红蛋白≥7 g/dL时,按推荐不予红细胞输注。
  • 该推荐仅适用于血流动力学稳定的严重脓毒症或脓毒性休克患儿,不适用于其他非出血性休克情形或血流动力学不稳定者。
  • 作者指出未来需研究确定非出血性休克患儿急性复苏期间的最佳输血阈值。

指南或共识出处

  • Pediatric Critical Care Transfusion and Anemia Expertise Initiative共识会议推荐,发表于Pediatric Critical Care Medicine。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「红旗征与不能漏的情况」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

OBJECTIVES: To present the recommendations and supporting literature for RBC transfusions in critically ill children with nonhemorrhagic shock developed by the Pediatric Critical Care Transfusion and Anemia Expertise Initiative.

DESIGN: Consensus conference series of international, multidisciplinary experts in RBC transfusion management of critically ill children.

METHODS: The panel of 38 experts developed evidence-based, and when evidence was lacking, expert-based clinical recommendations as well as research priorities for RBC transfusions in critically ill children. The nonhemorrhagic shock subgroup included five experts. Electronic searches were conducted using PubMed, EMBASE, and Cochrane Library databases from 1980 to May 2017. Agreement was obtained using the Research and Development/UCLA Appropriateness Method. Results were summarized using the Grading of Recommendations Assessment, Development, and Evaluation method.

RESULTS: Transfusion and Anemia Expertise Initiative Consensus Conference experts developed and voted on a total of four clinical and four research recommendations focused on RBC transfusion in the critically ill child with nonhemorrhagic shock. All recommendations reached agreement (> 80%). Of the four clinical recommendations, three were based on consensus panel expertise, whereas one was based on weak pediatric evidence. In hemodynamically stabilized critically ill children with a diagnosis of severe sepsis or septic shock, we recommend not administering a RBC transfusion if the hemoglobin concentration is greater than or equal to 7 g/dL. Future studies are needed to determine optimum transfusion thresholds for critically ill children with nonhemorrhagic shock undergoing acute resuscitation.

CONCLUSIONS: The Transfusion and Anemia Expertise Initiative Consensus Conference developed pediatric-specific clinical and research recommendations regarding RBC transfusion in the critically ill child with nonhemorrhagic shock. Although agreement among experts was strong, available pediatric evidence was scant-revealing significant gaps in the existing literature.

来源:Pediatr Crit Care Med,查看原文。版权归原作者所有。

参考来源

  1. Muszynski JA, Guzzetta NA, Hall MW, et al. Recommendations on RBC Transfusions for Critically Ill Children With Nonhemorrhagic Shock From the Pediatric Critical Care Transfusion and Anemia Expertise Initiative. Pediatr Crit Care Med. 2018. PMID: 30161066. doi:10.1097/PCC.0000000000001620

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。